INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 3 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $286 | +31.2% | 1,364 | 0.0% | 0.00% | – |
Q1 2023 | $218 | -78.2% | 1,364 | 0.0% | 0.00% | – |
Q4 2022 | $1,000 | 0.0% | 1,364 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 1,364 | -26.8% | 0.00% | – |
Q2 2022 | $1,000 | -50.0% | 1,864 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | -50.0% | 1,864 | 0.0% | 0.00% | – |
Q4 2021 | $4,000 | -33.3% | 1,864 | 0.0% | 0.00% | – |
Q3 2021 | $6,000 | +200.0% | 1,864 | +115.7% | 0.00% | – |
Q2 2021 | $2,000 | -33.3% | 864 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | +200.0% | 864 | +137.4% | 0.00% | – |
Q4 2020 | $1,000 | -94.1% | 364 | -97.4% | 0.00% | – |
Q3 2020 | $17,000 | +30.8% | 14,176 | 0.0% | 0.00% | – |
Q2 2020 | $13,000 | +8.3% | 14,176 | 0.0% | 0.00% | – |
Q1 2020 | $12,000 | – | 14,176 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 9,766,508 | $19,826,000 | 2.39% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,286,032 | $2,610,000 | 0.07% |
Clear Harbor Asset Management, LLC | 153,800 | $312,000 | 0.06% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 219,652 | $445,000 | 0.03% |
Rock Springs Capital Management LP | 270,000 | $548,000 | 0.02% |
Alambic Investment Management, L.P. | 77,665 | $158,000 | 0.02% |
Marshall Wace North America L.P. | 1,173,515 | $2,382,000 | 0.01% |
Baker Brothers Advisors | 580,400 | $1,178,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $932,000 | 0.01% |
Intellectus Partners, LLC | 13,000 | $26,000 | 0.01% |